Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
The South African National Aids Council is meant to play a co-ordinating role in the country’s response to HIV, bringing ...
The Ghana AIDS Commission (GAC) says the lack of funding can impact negatively efforts to end AIDS as a public health threat ...
Researchers assessed whether switching to protease inhibitor-based antiretroviral therapy mitigates or reverses weight gain in patients with HIV infection.
The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
New report shows an increase in HIV cases in Alberta. Experts tell Hiba Kamal-Choufi there should be a holistic approach to ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Zacks.com on MSN2d
Gilead, MRK Report Data From Investigational Combination Study for HIVGilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback